Corcept Therapeutics 公司的 ALS 药物在中期试验中失败

Reuters
12 Dec 2024

((自动化翻译由路透提供,请见免责声明 ))

路透12月11日 - Corcept Therapeutics 周三表示,其实验性药物未能达到对一种肌萎缩性脊髓侧索硬化症(一种致命的神经退行性疾病)患者进行中期试验的主要目标。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10